Volume 18, Issue 17, Pages (September 2008)

Slides:



Advertisements
Similar presentations
Volume 133, Issue 1, Pages (July 2007)
Advertisements

Volume 13, Issue 2, Pages (February 2011)
Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
Federico Dajas-Bailador, Emma V. Jones, Alan J. Whitmarsh 
Volume 11, Issue 4, Pages (April 2003)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 36, Issue 5, Pages (December 2009)
Volume 33, Issue 2, Pages (January 2009)
Volume 15, Issue 19, Pages (October 2005)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Teruaki Fujishita, Masahiro Aoki, Makoto M. Taketo  Gastroenterology 
Volume 87, Issue 7, Pages (December 1996)
Volume 22, Issue 5, Pages (May 2012)
Volume 13, Issue 2, Pages (February 2011)
Volume 137, Issue 5, Pages (May 2009)
Volume 18, Issue 23, Pages (December 2008)
Volume 16, Issue 18, Pages (September 2006)
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Volume 15, Issue 4, Pages (April 2008)
Volume 8, Issue 5, Pages (November 2001)
Volume 29, Issue 3, Pages (February 2008)
Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
PKA phosphorylates Thr63 and Ser692 to increase HIF-1α stability.
Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies  O.Jameel Shah,
Volume 18, Issue 3, Pages (February 2008)
Volume 2, Issue 6, Pages (June 2002)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe 
Volume 34, Issue 4, Pages (May 2009)
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 38, Issue 5, Pages (June 2010)
Volume 13, Issue 1, Pages (January 2008)
Ligand-Independent Recruitment of SRC-1 to Estrogen Receptor β through Phosphorylation of Activation Function AF-1  André Tremblay, Gilles B Tremblay,
Volume 45, Issue 6, Pages (March 2012)
Volume 22, Issue 2, Pages (April 2006)
Volume 17, Issue 2, Pages (January 2007)
Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase  Yosuke Yoneyama, Tomomi Inamitsu, Kazuhiro Chida, Shun-Ichiro.
Volume 10, Issue 1, Pages (July 2002)
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 10, Issue 3, Pages (September 2006)
Volume 17, Issue 6, Pages (June 2013)
Volume 20, Issue 5, Pages (March 2010)
Cdc28-Dependent Regulation of the Cdc5/Polo Kinase
Volume 14, Issue 14, Pages (July 2004)
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 96, Issue 6, Pages (March 1999)
Volume 23, Issue 5, Pages (September 2006)
Volume 25, Issue 5, Pages (March 2007)
Volume 52, Issue 2, Pages (October 2013)
Volume 20, Issue 18, Pages (September 2010)
Volume 24, Issue 21, Pages (November 2014)
Volume 21, Issue 12, Pages (June 2011)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 13, Issue 15, Pages (August 2003)
Volume 12, Issue 6, Pages (June 2005)
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Volume 34, Issue 6, Pages (June 2009)
Volume 16, Issue 16, Pages (August 2006)
Volume 15, Issue 14, Pages (July 2005)
Volume 34, Issue 2, Pages (April 2002)
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Phosphorylation and Functional Inactivation of TSC2 by Erk
Volume 23, Issue 2, Pages (August 2005)
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Association of CNK1 with Rho Guanine Nucleotide Exchange Factors Controls Signaling Specificity Downstream of Rho  Aron B. Jaffe, Alan Hall, Anja Schmidt 
Volume 57, Issue 2, Pages (January 2015)
Volume 129, Issue 5, Pages (June 2007)
Volume 22, Issue 3, Pages (May 2006)
Volume 58, Issue 3, Pages (May 2015)
Presentation transcript:

Volume 18, Issue 17, Pages 1269-1277 (September 2008) Oncogenic MAPK Signaling Stimulates mTORC1 Activity by Promoting RSK-Mediated Raptor Phosphorylation  Audrey Carrière, Marie Cargnello, Louis-André Julien, Huanhuan Gao, Éric Bonneil, Pierre Thibault, Philippe P. Roux  Current Biology  Volume 18, Issue 17, Pages 1269-1277 (September 2008) DOI: 10.1016/j.cub.2008.07.078 Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 1 RSK Phosphorylates Raptor In Vitro and in Cells Stimulated with Agonists of the Ras/MAPK Pathway (A) HEK293 cells were transfected with empty vector or Myc-tagged Raptor, serum-starved, and stimulated for 10 or 20 min with agonists of the Ras/MAPK and PI3K/Akt signaling pathways. Immunoprecipitated Raptor was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RXRXXpS/T consensus motif. (B and C) As in (A), but cells were pretreated with U0126 (10 μM), rapamycin (100 nM), or BI-D1870 (10 μM) for 30 min prior to PMA (50 ng/ml) stimulation. (D) HEK293 cells were cotransfected with control vector or Myc-tagged Raptor, and siRNA duplexes were targeted against a scrambled sequence (Scr), RSK1 or RSK2, serum-starved, and stimulated with PMA (50 ng/ml). Immunoprecipitated Raptor was then assayed as in (A). (E) HEK293 cells were cotransfected with Raptor and wild-type RSK1, constitutively activated RSK1 (myr), or kinase-inactive RSK1 (kd), serum starved, and stimulated with PMA (50 ng/ml). Immunoprecipitated Raptor was then assayed as in (A). (F) Immunoprecipitated HA-tagged wild-type or kinase-dead RSK1 (kd) from PMA-stimulated cells was incubated with immunopurified Raptor in a kinase reaction with γ[32P]ATP. The resulting samples were subjected to SDS-PAGE, and the dried Coomassie-stained gel was autoradiographed. (G) Samples were treated as in (F), but kinase reactions were performed without radioactivity. The resulting samples were immunoblotted for Raptor phosphorylation on RXRXXpS/T consensus sites. Current Biology 2008 18, 1269-1277DOI: (10.1016/j.cub.2008.07.078) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 2 Oncogenic Activation of the Ras/MAPK Pathway Promotes Constitutive Raptor Phosphorylation (A) Model depicting the Ras/MAPK pathway and inhibitors and activators used in this study. (B and C) HEK293 cells were cotransfected with Raptor and constructs expressing activated Ras (G12V), dominant-negative Ras (S17N), constitutively activated MEK1 (MEK-DD), or control vector and serum starved. Immunoprecipitated Raptor from unstimulated cells was then assayed for phosphorylation with the RXRXXpS/T phospho-motif antibody. (D) HEK293 cells were cotransfected with Raptor and wild-type ERK2, serum starved, stimulated with PMA, and analyzed as in (B). (E) HEK293 cells were either cotransfected with Raptor and MEK-DD, serum starved, and treated with BI-D1870 for 60 min (left panel) or cotransfected with control siRNA (Scr) or siRNAs targeted against RSK1 and RSK2 and serum starved (right panel). Immunoprecipitated Raptor was then assayed for phosphorylation as in (B). Current Biology 2008 18, 1269-1277DOI: (10.1016/j.cub.2008.07.078) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 3 Quantitative Mass Spectrometry Identifies and Profiles the Phosphorylation of Raptor upon Stimulation of the Ras/MAPK Pathway (A) Schematic representation of ion mapping and intensity normalization for determining changes in phosphorylation upon PMA stimulation and kinase inhibitor treatment. (B) Abundance ratios of different modified and invariant Raptor tryptic peptides normalized to unstimulated cells. A dotted line indicates no changes in abundance ratio. Results from three independent replicates are represented in a histogram as the means ± standard error. (C and D) MS/MS spectra of doubly protonated precursor at m/z 666.3 (C) and m/z 706.3 (D) corresponding to tryptic peptides LRpSVSSYGNIR and LRpSVSpSYGNIR, respectively. Fragment ions indicated correspond to y-type cleavages. (E) Schematic representation of the identified phosphorylation sites within Raptor. Current Biology 2008 18, 1269-1277DOI: (10.1016/j.cub.2008.07.078) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 4 Ser719, Ser721, and Ser722 are the Primary RSK-Dependent Phosphorylation Sites in Raptor (A) Schematic representation of the consensus motifs encompassing residues Ser719, Ser721, and Ser722 of Raptor. (B) Primary sequence alignment showing conservation of the three RSK-dependent phosphorylation sites within different Raptor orthologs. (C) HEK293 cells were transfected with wild-type Raptor or potential RSK-phosphorylation-site mutants S719A, S721A, S722A, and the triple mutant S719/721/722A (3A), serum starved, and stimulated with PMA for 20 min. Immunoprecipitated Raptor was then immunoblotted for phosphorylation at RXRXXpS/T sites. (D) As in (C), except cells were transfected with wild-type, 3A, or potential RSK-phosphorylation-site mutants (S59A and S791A) that were not identified by MS analysis. Raptor immunoprecipitates were then immunoblotted for phosphorylation at RXRXXpS/T sites. (E) As in Figure 2D, except that HA-tagged wild-type RSK1 immunoprecipitates were incubated with either wild-type Raptor or the 3A mutant in an in vitro kinase reaction. Current Biology 2008 18, 1269-1277DOI: (10.1016/j.cub.2008.07.078) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 5 RSK-Mediated Phosphorylation of Raptor Promotes mTORC1 Activity without Altering Raptor Interaction with mTOR or Its Substrates (A) Cells were cotransfected with HA-tagged 4E-BP1 and either wild-type Raptor or the 3A mutant, serum starved, and stimulated with PMA. Associated 4E-BP1 was assayed within Raptor immunoprecipitates by immunoblotting. (B) Cells were cotransfected with Flag-tagged mTOR and either wild-type Raptor or the 3A mutant, serum starved, and stimulated with PMA. Associated mTOR was assayed within Raptor immunoprecipitates. (C) Cells were cotransfected with mTOR and Raptor and serum starved, and mTORC1 kinase activity was assayed within Raptor immunoprecipitates, with GST-4EBP1 as a substrate. The kinase reaction was performed in the presence of γ[32P]ATP, the resulting samples were subjected to SDS-PAGE, and the dried Coomassie-stained gel was autoradiographed. (D) Cells were cotransfected with mTOR and wild-type Raptor or the 3A mutant, serum starved, and stimulated with PMA. mTORC1 activity was assayed as described in (A). (E) As in (D), except that cells were stimulated with insulin (100 nM) for 20 min. Current Biology 2008 18, 1269-1277DOI: (10.1016/j.cub.2008.07.078) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 6 The Ras/MAPK and PI3K/Akt Pathways Regulate mTORC1 Activation by a Twofold Mechanism Although Akt and RSK inactivate TSC2 and thereby promote Rheb GTP-loading, both kinases also directly regulate mTORC1 via alternative mechanisms. Whereas Akt phosphorylates PRAS40 to suppress its inhibitory function, RSK directly phosphorylates Raptor to promote mTORC1 activity. Current Biology 2008 18, 1269-1277DOI: (10.1016/j.cub.2008.07.078) Copyright © 2008 Elsevier Ltd Terms and Conditions